K

Kezar Life Sciences
D

KZR

4.24000
USD
-0.20
(-4.50%)
مغلق
حجم التداول
53
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
31,049,969
أصول ذات صلة الأخبار المقالات

العنوان: Kezar Life Sciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.